CVS has made Impax Laboratories’ epinephrine auto-injector available at all CVS Pharmacy drug stores at a cash price of $109.99 for a two-pack.
That compares with a cash price of $649.99 for the branded EpiPen and $339.99 for the EpiPen authorized generic that Mylan launched in December. Mylan has sparked controversy with the high price of its branded device.
“We recognized that there was an urgent need in the marketplace for a less expensive epinephrine auto-injector for patients with life-threatening allergies,” CVS Pharmacy president Helena Foulkes said. “Over the past year, nearly 150,000 people signed on to a petition asking for a lower cost epinephrine auto-injector option, and millions more were active in social media searching for a solution.
“In order to address this challenge, we have partnered with Impax to purchase their epinephrine auto-injector at a price that is lower than similar brand or authorized generic epinephrine auto-injectors. We are passing these savings along to our customers and patients, making this product available at all CVS Pharmacy locations at the lowest cash price in the market.”
The $109.99 price for the two-pack applies to insured patients and cash-paying patients without insurance. CVS noted that the cost will benefit insured patients who have consumer-directed health plans and haven’t yet met their deductible for the year.
Other price breaks for the generic product are available to qualifying patients through Impax’s coupon program, which provides a benefit of $100 per pack.
Impax’s product is a Food and Drug Administration-approved device. It is an authorized generic of Amedra Pharmaceuticals’ Adrenaclick, and it has the same active ingredient as other epinephrine auto-injector devices.
“We are thrilled to work with CVS Health to increase access to our low-cost generic Adrenaclick epinephrine auto-injector,” stated Douglas Boothe, president of Impax’s generics division. “Families need and deserve an affordable option to treat severe allergies.”